The Rosen Law Firm has reminded Blaize Holdings, Inc. (NASDAQ: BZAI) investors of the October 5, 2026 deadline to seek appointment as lead plaintiff in a federal securities class action. The litigation, first filed by the firm, challenges the company’s disclosures regarding its business operations and financial condition.

Kaplan Fox & Kilsheimer LLP issued a separate reminder regarding the same deadline on September 4, 2026. The complaint alleges that Blaize made materially false or misleading statements by announcing transactions with entities unequipped to conduct meaningful business. Specifically, the suit cites a $20 million deal with NeoTensr that was improperly recognized as revenue. Investors who purchased securities between July 18, 2025, and April 28, 2026, may be eligible for compensation.

Legal Landscape and Competing Firms

The Rosen Law Firm highlights its ranking as No. 1 by ISS Securities Class Action Services for settlements in 2017 and its recovery of billions for investors globally, including over $438 million in 2019 alone. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. The firm notes that many other firms issuing notices may act merely as middlemen rather than litigators.

Kaplan Fox & Kilsheimer LLP, founded in 1956, has recovered more than $10 billion for clients. Notable recoveries include $2.425 billion for Bank of America shareholders, $800 million for the Arkansas Teacher Retirement System in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch. The firm is widely regarded as one of the nation's premier plaintiffs' securities litigation firms.

Other firms actively involved in the case include Robbins LLP, Johnson Fistel, PLLP, Faruqi & Faruqi, LLP, Glancy Prongay Wolke & Rotter LLP, The Law Offices of Frank R. Cruz, The Portnoy Law Firm, Pomerantz LLP, and Bragar Eagel & Squire, P.C.

Robbins LLP has helped recover more than $1 billion for investors. Johnson Fistel recovered approximately $90.7 million for aggrieved investors in 2024. Pomerantz LLP continues its tradition of fighting securities fraud and has secured numerous multimillion-dollar damages awards. Bragar Eagel & Squire, a nationally recognized stockholder rights law firm, also urges investors to contact them.

Allegations and Stock Impact

The lawsuit centers on Blaize’s $20 million transaction with NeoTensr, a partner entity incorporated in December 2025 with approximately $2 million in startup capital. Blaize recognized this amount as Q4FY26 revenue despite the partner’s limited operational history. The company had previously announced the agreement was expected to generate up to $50 million in revenue.

On April 28, 2026, Pelican Way Research published a short report alleging that Blaize artificially boosted its share price through a bogus deal with the four-month-old counterparty. The report noted that NeoTensr’s website featured products appearing to be photoshopped with the Blaize logo. Following the report, Blaize’s stock fell 12.03%, closing at $1.90 per share on April 28, 2026.

Investor Eligibility and Next Steps

Investors who purchased Blaize securities between July 18, 2025, and April 28, 2026, may be eligible for compensation without upfront fees through a contingency fee arrangement. To serve as lead plaintiff—a role granting significant influence over settlement negotiations—investors must move the Court no later than October 5, 2026. Those who do not seek this role may still share in any eventual settlement as absent class members.

No class has been certified. Until a class is certified, investors are not represented by counsel unless they retain one. Investors may select counsel of their choice or remain an absent class member. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Interested parties can contact The Rosen Law Firm via Phillip Kim, Esq., at case@rosenlegal.com or by phone at 866-767-3653. Alternatively, investors may contact Kaplan Fox via email at pmayer@kaplanfox.com or by phone at (646) 315-9003. Investors may also contact Jim Baker at Johnson Fistel via email at jimb@johnsonfistel.com or by phone at (619) 814-4471, or Danielle Peyton at Pomerantz LLP via email at newaction@pomlaw.com or by phone at 646-581-9980, Ext. 7980. Investors may also contact The Law Offices of Frank R. Cruz at 310-914-5007 or by email to fcruz@frankcruzlaw.com .

Investors seeking additional information about the Blaize Holdings, Inc. securities class action may contact Robbins LLP by emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003. Additionally, investors can contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Blaize Holdings Inc (NASDAQ: BZAI) faces a securities investigation after slashing its full-year revenue guidance by approximately 68%. The company lowered its outlook from $130 million to a range of $40–$43 million on August 13, 2026, citing commercial opportunities that "did not materialize as expected" and higher memory costs. Shares traded below $0.64 on August 14, more than 65% below the May public offering price of $1.85.

Johnson Fistel PLLP is investigating whether Blaize or certain executive officers violated federal securities laws in connection with revenue guidance, customer agreements, purchase orders, accounts receivable, and pipeline metrics. The firm is seeking investors who suffered losses to participate in the investigation.

Customer Deal Risks

The guidance cut follows disclosures regarding significant risks in key customer relationships. Blaize’s Form 10-Q revealed that Starshine issued only one $10.4 million purchase order, of which $8.8 million remained unpaid. This receivable was transferred to Blaize’s wholly owned Chinese subsidiary, with a third-party agent pursuing payment. Blaize fully reserved the receivable, warning of substantial risk that collection efforts might fail. Management stated it would not engage further with Starshine unless the outstanding balance was paid.

Regarding NeoTensr, Blaize disclosed that a previous $23.8 million receivable was paid in full, driving second-quarter revenue momentum. However, an April 2026 agreement for up to $50 million remained subject to purchase orders. As of August 13, NeoTensr had issued only one $13.7 million purchase order. On August 7, the agreement was amended to establish a firm contract with a minimum purchase commitment, known as a take-or-pay arrangement.

Pipeline Metric Changes

Blaize announced it no longer considers its previously reported pipeline metrics to be key business metrics. The company determined these figures were "not as closely connected with future revenue as previously expected" and stated it did not expect to present them in future filings.

What the Numbers Show

The divergence between Blaize’s initial $130 million guidance and the revised $40–$43 million midpoint highlights a severe disconnect between planned commercial cadence and actual execution. With only $13.7 million in confirmed purchase orders from NeoTensr against a $50 million potential agreement, and a fully reserved $8.8 million receivable from Starshine, the company’s near-term revenue visibility appears heavily dependent on the new take-or-pay structure with NeoTensr rather than organic order inflow.